ATE152619T1 - Biologisch abbaubarer partikelförmiger vektor und syntheseverfahren - Google Patents

Biologisch abbaubarer partikelförmiger vektor und syntheseverfahren

Info

Publication number
ATE152619T1
ATE152619T1 AT92911799T AT92911799T ATE152619T1 AT E152619 T1 ATE152619 T1 AT E152619T1 AT 92911799 T AT92911799 T AT 92911799T AT 92911799 T AT92911799 T AT 92911799T AT E152619 T1 ATE152619 T1 AT E152619T1
Authority
AT
Austria
Prior art keywords
synthesis method
particulate vector
biodegradable particulate
linked
vector
Prior art date
Application number
AT92911799T
Other languages
English (en)
Inventor
Daniel Samain
Miguel Ignacio De
Jaouad Meniali
Karim Ioualalen
Li Ding
Monique Cervilla
Valerie Rieumajou
Pascal Delrieu
Laurent Imbertie
Original Assignee
Biovector Therapeutics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovector Therapeutics Sa filed Critical Biovector Therapeutics Sa
Application granted granted Critical
Publication of ATE152619T1 publication Critical patent/ATE152619T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Wrappers (AREA)
  • Laminated Bodies (AREA)
AT92911799T 1991-06-04 1992-06-04 Biologisch abbaubarer partikelförmiger vektor und syntheseverfahren ATE152619T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9106743A FR2677249B1 (fr) 1991-06-04 1991-06-04 Vecteur particulaire biodegradable et procede de synthese.

Publications (1)

Publication Number Publication Date
ATE152619T1 true ATE152619T1 (de) 1997-05-15

Family

ID=9413451

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92911799T ATE152619T1 (de) 1991-06-04 1992-06-04 Biologisch abbaubarer partikelförmiger vektor und syntheseverfahren

Country Status (11)

Country Link
EP (1) EP0542969B1 (de)
JP (1) JPH06500570A (de)
KR (1) KR100258521B1 (de)
AT (1) ATE152619T1 (de)
CA (1) CA2088759A1 (de)
DE (1) DE69219561T2 (de)
DK (1) DK0542969T3 (de)
ES (1) ES2103032T3 (de)
FR (1) FR2677249B1 (de)
GR (1) GR3024217T3 (de)
WO (1) WO1992021329A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654006A (en) * 1993-02-12 1997-08-05 Mayo Foundation For Medical Education And Research Condensed-phase microparticle composition and method
EP0684812B1 (de) * 1993-02-12 1998-01-21 Mayo Foundation For Medical Education And Research Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren
FR2702160B1 (fr) 1993-03-02 1995-06-02 Biovecteurs As Vecteurs particulaires synthétiques et procédé de préparation.
FR2704145B1 (fr) * 1993-04-21 1995-07-21 Pasteur Institut Vecteur particulaire et composition pharmaceutique le contenant.
FR2754828B1 (fr) * 1996-10-23 1998-12-24 Univ Toulouse Structure membranaire artificielle, procede et polymere pour sa preparation, procede de preparation de ce polymere, particule et film comprenant cette structure
FR2757876B1 (fr) * 1996-12-27 1999-04-09 Biovector Therapeutics Sa Conjuges d'un vecteur particulaire et d'oligonucleotides, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2765496B1 (fr) * 1997-07-03 1999-09-24 Rosanne Raynal Microbilles appelees capsules a coeur polymerique capables de transporter des molecules, des principes actifs et/ou des cellules.
BRPI0801929A2 (pt) * 2008-05-13 2010-01-12 Santana Cristiano Alberto Ribeiro processo e composição farmacêutica compreendendo enzimas proteolìticas vegetais em nanopartìculas supramoleculares, para tratamento da doença de peyronie, colagenoses e patologias fibróticas e uso
US8716219B2 (en) * 2009-07-07 2014-05-06 Sabanci University Crosslinked protein nanocrystals, crosslinked protein nanoaggregates and method of preparation thereof
HUE030071T2 (en) 2009-12-04 2017-04-28 Magle Ab Endogenous hydrolysed microparticles containing charged ligands
WO2013048762A1 (en) * 2011-09-29 2013-04-04 Dow Global Technologies Llc In-situ method for preparing hydrolyzed acyl halide compound
WO2014026284A1 (en) * 2012-08-14 2014-02-20 Froese Aaron Internal structured self assembling liposomes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631826B1 (fr) * 1988-05-27 1992-06-19 Centre Nat Rech Scient Vecteur particulaire utile notamment pour le transport de molecules a activite biologique et procede pour sa preparation
FR2646777B1 (fr) * 1989-05-12 1993-09-03 Bio Serae Lab Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications

Also Published As

Publication number Publication date
JPH06500570A (ja) 1994-01-20
GR3024217T3 (en) 1997-10-31
CA2088759A1 (fr) 1992-12-05
WO1992021329A1 (fr) 1992-12-10
FR2677249A1 (fr) 1992-12-11
DE69219561D1 (de) 1997-06-12
DK0542969T3 (da) 1997-11-03
EP0542969B1 (de) 1997-05-07
FR2677249B1 (fr) 1995-03-17
KR100258521B1 (ko) 2000-08-01
DE69219561T2 (de) 1997-11-13
ES2103032T3 (es) 1997-08-16
KR930701158A (ko) 1993-06-11
EP0542969A1 (de) 1993-05-26

Similar Documents

Publication Publication Date Title
DE69219561D1 (de) Biologisch abbaubarer partikelförmiger vektor und syntheseverfahren
DE60027774D1 (de) Dreidimensionale matrixfilme
DE68901955D1 (de) Insbesondere zum tragen von biologisch aktiven molekuelen geeignetes teilchenfoermiges vektorsystem und verfahren zu seiner herstellung.
DK0696612T3 (da) Bionedbrydelige opskummede artikler og fremgangsmåde til fremstilling deraf
SE9503380D0 (sv) Protein derivatives
FI912016L (fi) In vitro -menetelmä antigeenispesifisten ihmisen monoklonaalisten vasta-aineiden valmistamiseksi
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
NO974970L (no) Fremgangsmåte til behandling av seismiske data for å tilveiebringe forplantningstidskurven
AU2070592A (en) Photopolymer composition for the production of three-dimensional objects
NL192208B (nl) Werkwijze voor het bereiden van met difterie-toxine verwante eiwitten.
EP0668772A4 (de) Spezifische modulationen des immunsystems.
IT1277377B1 (it) Metodo per l'aggiornamento continuo dell'immagine sismica bidimensionale e tridimensionale in profondita' mediante
Nitta et al. Fc gamma 2b receptor-mediated prostaglandin synthesis by a murine macrophage cell line (P388D1).
ATE399022T1 (de) Zusammensetzung und verfahren zur verstärkung der immunantwort antigen-präsentierender zellen
NO310747B2 (no) Fremgangsmate for generering av seismiske skjaerbolger i havbunnen
DE69124705D1 (de) Hexapeptide als liganden des anaphylatoxin-rezeptors
DE69619257D1 (de) Die konjugation von liganden an immobilisierte proteine in einem organischen lösungsmittel
FR2623800B1 (fr) Procede de preparation d'alcools insatures
NL194757B (nl) Werkwijze voor het bereiden van een suspensie van calciumhydroxide en/of magnesiumhydroxide in water.
NL1004345A1 (nl) Zoutoplossing voor het produceren van sojasaus en werkwijze voor het produceren van sojasaus.
NL190689C (nl) Werkwijze voor het steriliseren van een perceel grond.
NL194358B (nl) Samenstel voor het kweken van planten.
NL192423B (nl) Werkwijze voor het verbeteren van sommige functionele eigenschappen van eiwitachtig materiaal.
ATE8663T1 (de) Verfahren zum immobilisieren mikrobischer, kugelfoermiger zellen durch adhaesion an ein festes traegermaterial.
DE4291301T1 (de) Hologramme und Holographie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee